Wright Medical Group Inc. Rt | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
310,959.00
298,027.00
415,461.00
690,362.00
744,989.00
Cost of Goods Sold (COGS) incl. D&A
115,957.00
83,250.00
136,177.00
221,248.00
216,443.00
Gross Income
195,002.00
214,777.00
279,284.00
469,114.00
528,546.00
SG&A Expense
215,338.00
314,583.00
469,253.00
558,472.00
535,837.00
EBIT
20,336.00
-
189,969.00
87,358.00
7,291.00
Unusual Expense
4,865.00
2,000.00
15,200.00
44,300.00
12,900.00
Non Operating Income/Expense
1,865.00
127,626.00
4,316.00
11,848.00
5,070.00
Interest Expense
7,256.00
17,398.00
41,358.00
58,530.00
74,644.00
Pretax Income
34,077.00
246,830.00
242,211.00
178,340.00
99,905.00
Income Tax
2,349.00
6,334.00
3,851.00
13,406.00
34,968.00
Consolidated Net Income
36,426.00
240,496.00
238,360.00
164,934.00
64,937.00
Net Income
36,426.00
240,496.00
238,360.00
164,934.00
64,937.00
Net Income After Extraordinaries
36,426.00
221,309.00
178,019.00
102,505.00
72,724.00
Net Income Available to Common
36,426.00
259,683.00
298,701.00
432,373.00
64,937.00
EPS (Basic)
0.79
5.06
4.61
4.20
1.94
Basic Shares Outstanding
45,826.00
51,293.00
64,808.00
102,968.00
104,531.00
EPS (Diluted)
0.79
5.06
4.61
4.20
1.94
Diluted Shares Outstanding
45,826.00
51,293.00
64,808.00
102,968.00
104,531.00
EBITDA
16,230.00
71,197.00
143,566.00
1,396.00
77,937.00
Other Operating Expense
-
-
-
2,000.00
-
Non-Operating Interest Income
245.00
-
-
-
-

About Wright Medical Group

View Profile
Address
Prins Bernhardplein 200
Amsterdam Noord-Holland 1097 JB
Netherlands
Employees -
Website http://www.wright.com
Updated 09/14/2018
Wright Medical Group NV operates as a global medical device company, which engages in the design, manufacture, and distribution of biologic products. It provides surgical solutions for the foot and ankle market and its products include large joint implants for the hip and knee, extremity implants for the shoulder, elbow, hand, wrist and foot and biologic products, including bone graft substitutes. The company was founded by Frank O.